Ming-Cheng Chen Selected Research

taiwanin C

1/2017	Down-regulation of β-catenin and the associated migration ability by Taiwanin C in arecoline and 4-NQO-induced oral cancer cells via GSK-3β activation.
1/2017	Taiwanin C selectively inhibits arecoline and 4-NQO-induced oral cancer cell proliferation via ERK1/2 inactivation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Cheng Chen Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 07/2011
10	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2013
8	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 02/2017
7	Colonic Neoplasms (Colon Cancer) 10/2021 - 07/2014
6	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2013
4	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2013
2	Osteosarcoma (Osteogenic Sarcoma) 08/2019 - 02/2018
2	Carcinogenesis 06/2018 - 01/2017
2	Mouth Neoplasms (Oral Cancer) 01/2017 - 01/2017
2	Fibrosis (Cirrhosis) 01/2017 - 01/2016
2	Rectal Neoplasms (Rectal Cancer) 07/2011 - 02/2011
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 05/2022
1	Adenocarcinoma of Lung 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Bacterial Infections (Bacterial Infection) 08/2020
1	Infections 01/2019
1	Disease Progression 01/2018
1	Heart Failure 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Cardiomegaly (Heart Hypertrophy) 01/2016
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016
1	Inflammation (Inflammations) 07/2015
1	IGA Glomerulonephritis (IGA Nephropathy) 07/2015
1	Sclerosis 07/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2015
1	Margins of Excision 07/2011
1	Enterocolitis 02/2011
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2011
1	Prostatic Neoplasms (Prostate Cancer) 02/2011
1	Intestinal Obstruction (Obstruction, Intestinal) 02/2011

Drug/Important Bio-Agent (IBA)

7	CateninsIBA 02/2017 - 01/2013
6	Histone Deacetylase InhibitorsIBA 01/2022 - 01/2014
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2014
5	Pharmaceutical PreparationsIBA 01/2022 - 07/2014
5	Irinotecan (Camptosar)FDA LinkGeneric 10/2021 - 07/2014
4	apicidinIBA 01/2021 - 01/2013
4	fisetinIBA 11/2020 - 01/2018
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2019 - 01/2018
3	Messenger RNA (mRNA)IBA 05/2022 - 01/2013
3	thymoquinoneIBA 02/2017 - 02/2015
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2022 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2019
2	Protein Phosphatase 1IBA 11/2020 - 06/2019
2	Transcription Factors (Transcription Factor)IBA 10/2019 - 01/2017
2	taiwanin CIBA 01/2017 - 01/2017
2	Arecoline (Arecolin)IBA 01/2017 - 01/2017
1	Tannic Acid FDA Link 12/2022
1	Antineoplastic Agents (Antineoplastics)IBA 12/2022
1	CalreticulinIBA 01/2022
1	daidzeinIBA 01/2022
1	Gefitinib (Iressa)FDA Link 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	TriterpenesIBA 02/2021
1	SaponinsIBA 02/2021
1	platycodin DIBA 02/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2021
1	human MIRN107 microRNAIBA 01/2021
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2021
1	VaccinesIBA 08/2020
1	Doxycycline (Periostat)FDA LinkGeneric 05/2020
1	Biomarkers (Surrogate Marker)IBA 05/2020
1	Phosphotransferases (Kinase)IBA 10/2019
1	3-hydroxyflavoneIBA 08/2019
1	FlavonoidsIBA 06/2019
1	EugenolIBA 01/2019
1	jasmonic acid (jasmonate)IBA 01/2019
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 01/2019
1	anise oilIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 06/2018
1	lupeolIBA 05/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2018
1	PlatinumIBA 01/2018
1	Leucovorin (Folinic Acid)FDA Link 01/2018
1	AntioxidantsIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	regorafenibIBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	Dinoprostone (PGE2)FDA Link 02/2017
1	PhytochemicalsIBA 02/2017
1	Estrogens (Estrogen)FDA Link 02/2017
1	beta CateninIBA 01/2017
1	CarcinogensIBA 01/2017
1	Anthocyanins (Anthocyanin)IBA 01/2016
1	Streptozocin (Streptozotocin)FDA Link 01/2016
1	ResveratrolIBA 07/2015
1	CaspasesIBA 02/2015
1	ErbB Receptors (EGF Receptor)IBA 07/2014
1	NF-kappa B (NF-kB)IBA 07/2014
1	Topoisomerase I InhibitorsIBA 07/2014
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2014
1	Serum AlbuminIBA 02/2011

Therapy/Procedure

8	Therapeutics 12/2022 - 02/2011
3	Drug Therapy (Chemotherapy) 01/2018 - 07/2014
1	Subcutaneous Injections 05/2020
1	Injections 05/2018
1	Combination Drug Therapy (Combination Chemotherapy) 01/2018
1	Operative Surgical Procedures 01/2014
1	Pelvic Exenteration 07/2011